| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6e1bd09ef41b0d3fecd0911926fa81e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45459006f50e8db24e4ecc5eed095d52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e33d174b0cb3030a0b4651f6a655ec9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b08711d67aee6857b85654c01cc8b211
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a169ec36396562ce6d0be9167992b89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b3203bae97c3b0a6baaa786fd4de95e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-52 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B03B9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00 |
| filingDate |
2005-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c0af6c6dbd90cf968903f24bd5f9b86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97722913d4e4110b1ff3d66202b4d9f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0fb5f5d51ce02e7805bbeb5ec99f342
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31d6674157ec72db9677c57b0b7aa104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8a216fe9f620253e01745d0841e52fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_560532dd05af45fe41e8d26733702c0a |
| publicationDate |
2008-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008115247-A1 |
| titleOfInvention |
Chemical Process |
| abstract |
Enzymatic and chemical processes for the preparation of certain of 3-phenyl-2-arylalkylthiopropionic acid derivatives which have utility in treating clinical conditions including lipid disorders (dyslipidemias) whether or not associated with insulin resistance and other manifestations of the metabolic syndrome are described and also certain novel intermediates used in these processes. |
| priorityDate |
2004-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |